{
    "ticker": "REGN",
    "name": "Regeneron Pharmaceuticals, Inc.",
    "description": "Regeneron Pharmaceuticals, Inc. is a leading biotechnology company focused on the discovery, development, and commercialization of innovative medicines for the treatment of serious diseases. Founded in 1988 and headquartered in Tarrytown, New York, Regeneron has made significant advancements in various therapeutic areas, including ophthalmology, oncology, immunology, and infectious diseases. The company is widely recognized for its flagship products, such as EYLEA (aflibercept), a treatment for retinal diseases, and Dupixent (dupilumab), which treats asthma and other allergic conditions. Regeneron's unique capabilities in genetic research and its proprietary VelociSuite\u00ae technology platform have enabled it to rapidly advance its drug discovery and development processes. The company's commitment to scientific excellence and innovation is reflected in its robust pipeline of investigational therapies, including treatments for conditions like atopic dermatitis, asthma, and various cancers. Regeneron is also deeply engaged in public health efforts, having developed the REGN-COV2 antibody cocktail for the treatment and prevention of COVID-19. With a mission to use the power of science to bring new medicines to patients, Regeneron continues to be a frontrunner in the biotechnology sector, striving to improve the lives of individuals around the world.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Tarrytown, New York, USA",
    "founded": "1988",
    "website": "https://www.regeneron.com",
    "ceo": "Leonard S. Schleifer",
    "social_media": {
        "twitter": "https://twitter.com/regeneron",
        "linkedin": "https://www.linkedin.com/company/regeneron-pharmaceuticals/"
    },
    "investor_relations": "https://investor.regeneron.com",
    "key_executives": [
        {
            "name": "Leonard S. Schleifer",
            "position": "CEO"
        },
        {
            "name": "George D. Yancopoulos",
            "position": "President and Chief Scientific Officer"
        }
    ],
    "product_categories": [
        {
            "category": "Ophthalmology",
            "products": [
                "EYLEA"
            ]
        },
        {
            "category": "Immunology",
            "products": [
                "Dupixent"
            ]
        },
        {
            "category": "Infectious Diseases",
            "products": [
                "REGN-COV2"
            ]
        }
    ],
    "seo": {
        "meta_title": "Regeneron Pharmaceuticals, Inc. | Innovative Medicines in Biotechnology",
        "meta_description": "Explore Regeneron Pharmaceuticals, Inc., a biotechnology leader dedicated to developing innovative medicines for serious diseases, including EYLEA and Dupixent.",
        "keywords": [
            "Regeneron",
            "Biotechnology",
            "Pharmaceuticals",
            "Innovative Medicines",
            "EYLEA",
            "Dupixent",
            "REGN-COV2"
        ]
    },
    "faq": [
        {
            "question": "What is Regeneron known for?",
            "answer": "Regeneron is known for its innovative medicines, particularly in ophthalmology and immunology, including EYLEA and Dupixent."
        },
        {
            "question": "Who is the CEO of Regeneron?",
            "answer": "Leonard S. Schleifer is the CEO of Regeneron Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Regeneron headquartered?",
            "answer": "Regeneron is headquartered in Tarrytown, New York, USA."
        },
        {
            "question": "What are Regeneron's main products?",
            "answer": "Regeneron's main products include EYLEA, Dupixent, and REGN-COV2."
        },
        {
            "question": "When was Regeneron founded?",
            "answer": "Regeneron was founded in 1988."
        }
    ],
    "competitors": [
        "AMGN",
        "GILD",
        "BIIB",
        "VRTX"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRNA",
        "ABBV"
    ]
}